- Home
- FLUX vs TXMD Comparison
FLUX vs TXMD Comparison
Compare FLUX & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLUX | TXMD |
|---|---|---|
| Founded | N/A | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.1M | 25.9M |
| IPO Year | 2019 | 2012 |
Fundamental Metrics
Financial Performance| Metric | FLUX | TXMD |
|---|---|---|
| Price | $1.21 | $2.30 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 175.3K | 20.1K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 20.00 | ★ 80.61 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,317,000.00 | $1,761,000.00 |
| Revenue This Year | N/A | $427.09 |
| Revenue Next Year | $23.01 | N/A |
| P/E Ratio | ★ N/A | $90.64 |
| Revenue Growth | ★ 126.25 | 35.25 |
| 52 Week Low | $1.01 | $0.84 |
| 52 Week High | $7.55 | $2.95 |
Technical Indicators
Market Signals| Indicator | FLUX | TXMD |
|---|---|---|
| Relative Strength Index (RSI) | 39.51 | 58.03 |
| Support Level | $1.04 | $2.10 |
| Resistance Level | $1.52 | $2.35 |
| Average True Range (ATR) | 0.11 | 0.11 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 12.89 | 96.43 |
Price Performance
Historical ComparisonAbout FLUX Flux Power Holdings Inc.
Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.